Salibay, Christina D.

HRN: 26-64-11  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2025
CEFUROXIME 1.5GM (VIAL)
02/06/2025
02/07/2025
IV
1.5 Grams
Q8
SP NSVD
Waiting Final Action 
02/06/2025
CEFUROXIME 500MG (TAB)
02/07/2025
02/13/2025
PO
500 Mg Tab
BID
SP NSVD
Waiting Final Action 
02/07/2025
CEFUROXIME 1.5GM (VIAL)
02/07/2025
02/08/2025
IV
1.5g
Q8
Nsvd Wbc 29
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: